Cellestia Biotech
Cellestia develops targeted therapies for cancer patients with no other options, including orphan cancers and childhood leukemia.
15 employees · est. 2014 · Basel, Switzerland
Plus Therapeutics, Inc.
Power and precision in cancer radiotherapeutics.
27 employees · est. 2019 · Houston, United States
Cellestia Biotech is the older company (2014 vs 2019).
Side-by-Side Comparison
| Metric | Cellestia Biotech | Plus Therapeutics, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2014 older | 2019 |
| Headquarters | ||
| Headquarters | Basel, Switzerland | Houston, United States |
| Employees | ||
| Employees | 15 | 27 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Non Equity Assistance | IPO |
| Total Funding | ||
| Total Funding | $48.17M | $80.90M |
| Funding Rounds | ||
| Funding Rounds | 10 | 8 |
| Services | ||
| Services | Not tracked yet | Development of targeted radiotherapeutics, Clinical trials for cancer therapies, Research on drug delivery systems for cancer treatment, Diagnostics for CNS cancer |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with rare and difficult-to-treat cancers, Healthcare providers specializing in oncology, Pharmaceutical companies looking for partnerships, Investors in biopharma |
| Taxonomy | ||
| Taxonomy | Biotech, Cancer Therapy, Targeted Therapies, Orphan Cancers, Childhood Leukemia, Autoimmune Diseases, Multi-drug Resistant Cancers, Clinical Stage Drug Candidate, CB-103, Proof-of-Concept Clinical Study, GvHD, Innovative Therapeutics, Novel Modes Of Action, IITs, Biological Activity | Clinical-stage Pharmaceuticals, Radiotherapeutics, Targeted Therapy, Rare Cancers, Glioblastoma, Leptomeningeal Metastases, Pediatric Brain Cancer, Nanotechnology, Oncology, Radiopharmaceuticals, Innovative Drug Development, Nanomedicine, Drug Delivery, Clinical Trials, Liposome Technology |
| Website | ||
| Website | cellestia.com | plustherapeutics.com |
About Cellestia Biotech
Cellestia Biotech is a Swiss-based biopharma startup founded in 2014. The company's mission is to develop targeted therapies for cancer patients with no other options, with a focus on orphan cancers and childhood leukemia. Their flagship drug candidate, CB-103, has shown promising results in terms o...
About Plus Therapeutics, Inc.
Plus Therapeutics, Inc., known for its slogan "Power and precision in cancer radiotherapeutics," stands as a noteworthy player in the pharmaceutical industry. Founded in 2019, this U.S.-based clinical-stage company is focused on developing cutting-edge radiotherapeutics targeted at rare and challeng...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Cellestia Biotech and Plus Therapeutics, Inc. — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Cellestia Biotech and Plus Therapeutics, Inc... — by email.
Frequently Asked Questions
Compare Cellestia Biotech with someone else
Start typing a company name or domain.